Refine by
Drug Conjugate Articles & Analysis
78 articles found
PEG derivatives are widely used in modern drug development because they can improve solubility, support formulation stability, and provide flexible conjugation options. They are commonly applied in lipid nanoparticles, ADCs, PROTACs, polymer-drug conjugates, click chemistry, and surface modification. With increasing demand for ...
In the fast-evolving field of antibody–drug conjugates (ADCs), linker chemistry plays a decisive role in defining therapeutic performance. The ability to control the drug-to-antibody ratio (DAR), conjugation site, and overall molecular stability directly impacts both efficacy and safety. ...
l Complex product formats: Bispecific antibodies, antibody-drug conjugates, and fusion proteins introduce unique purification challenges. ...
Challenges in Fluorescent Labeling Labeling biopolymers with fluorescent groups presents several key challenges: l Efficiency: Chemical conjugation efficiency can drop significantly under non-optimal conditions. ...
ByMatexcel
One notable application of chemical synthesis is in the development of lipid conjugates used in drug delivery systems. Researchers can design lipids with specific hydrophilicity and hydrophobicity, enhancing the bioavailability and targeting capability of therapeutic agents. ...
Antibody-drug conjugates (ADCs) combine potent small-molecule drugs with monoclonal antibodies for targeted cancer therapy. A major challenge is loading enough drug onto each antibody without compromising solubility or circulation time. ...
This article explores the mechanisms, benefits, challenges, and future prospects of PEGylation in drug development. Mechanism of PEGylation PEGylation involves the covalent or non-covalent attachment of PEG—a synthetic, hydrophilic polymer—to a drug molecule. The process typically uses reactive PEG derivatives (e.g., methoxy-PEG or ...
Despite these hurdles, biologics continue their rapid growth, with innovations like antibody-drug conjugates and bispecific antibodies expanding treatment possibilities for previously untreatable conditions. ...
Understanding Radioactive Drug Conjugates Radioactive drug conjugates are engineered to deliver radiation directly to cancer cells while sparing healthy tissues. ...
Alfa Cytology has officially released its antibody-drug conjugates(ADCs) development services which demonstrates the dedication to fighting cancer through advanced treatment methods. Alfa Cytology, which stands at the forefront of oncology service provision in New York United States, has announced its sophisticated antibody-drug ...
Antibody-Drug Conjugates (ADCs) represent a groundbreaking advancement in targeted cancer therapy, combining the specificity of antibodies with the potency of cytotoxic drugs. ...
Research Tools: Researchers utilize single-domain antibodies in various applications, such as protein purification and label-free detection systems, due to their ability to bind specific targets with high affinity. Targeted Drug Delivery: Their small size allows them to be conjugated with drugs or therapeutic agents for targeted delivery, ...
Antibody drugs are a kind of drugs that treat diseases through artificially synthesized antibodies, achieving therapeutic purposes by specifically binding with target molecules. Common types of antibody drugs include monoclonal antibodies, artificially synthesized antibody fragments, immunotoxins, antibody-drug ...
Among the most promising strategies in this endeavor are the use of tumor models for breast cancer and the development of customized antibody-drug conjugates (ADCs). These advancements not only enhance our understanding of the disease but also pave the way for more targeted therapeutic solutions. ...
The design of drug delivery systems often involves conjugating therapeutic agents to proteins, enhancing the efficacy and targeting of drugs. In cancer treatment, for example, antibody-drug conjugates allow for the targeted delivery of chemotherapy directly to tumor cells, minimizing damage to healthy tissues. ...
Antibody drugs are a type of drugs that treat diseases through artificially synthesized antibodies, which bind specifically to target molecules for therapeutic purposes. Common types of antibody drugs include monoclonal antibodies, artificially synthesized antibody fragments, immunotoxins, and antibody-drug ...
Antibody-drug conjugates (ADCs) are a new class of drugs that combine the advantages of both antibodies and small molecule toxins. ...
Antibody-drug conjugates (ADCs) represent a groundbreaking class of therapeutics that combine the specificity of monoclonal antibodies (mAbs) with the potent cytotoxic effects of small-molecule drugs. ...
By conjugating PEG chains to drug molecules, pharmaceutical companies can create formulations that dissolve more readily in biological fluids, ensuring that the active ingredient reaches its target site in the body. Prolonging Drug Half-Life The process of PEGylation, which involves attaching PEG chains to therapeutic molecules, has been a ...
Polypeptide drugs are bioactive molecules formed by the connection of multiple amino acids through peptide bonds. ...